Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma

NCT01386710 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

54

Enrollment

OTHER

Sponsor class

Stopped PI left previous institution study will reopen at new institution.

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma

Interventions

DRUG: Bevacizumab and Carboplatin
DRUG: Bevacizumab and Carboplatin

Sponsor

Northwell Health